Intratumoral delivery of Flagrp170 using an adenovirus induced a superior anti-tumor response against treated B16 melanoma and distant lung metastases compared with unmodified GRP170 or Flagellin treatment (173), which indicates systemic mobilization of tumor-reactive immune effector cells. Here, HYOU1 is linked to melanoma.